Similarly, in cervical cancer, the overexpression of EZH2 promotes tumor progression by enhancing cell proliferation and tumor formation through activation of the Wnt/β-catenin pathway, achieved via epigenetic silencing of GSK-3β and TP53 [135]. Here, EZH2 is linked to cervical cancer.